No Data
LIVZON PHARMA (01513.HK) spent 10 million yuan to repurchase 0.2737 million A-shares on January 27.
Gelonghui, January 27th丨LIVZON PHARMA (01513.HK) announced that on January 27, 2025, it spent 10 million yuan to repurchase 0.2737 million A-shares, with a repurchase price of 36.33-36.79 yuan per share.
Livzon Pharmaceutical Group's Drug Gets NMPA's Approval for Registration
Express News | Livzon Says Nmpa Accepts Market Authorization Application of Co's Drug "Recombinant Human Follitropin Alfa Solution for Injection"
On January 24, LIVZON PHARMA (01513.HK) spent 10.5315 million yuan to repurchase 0.2918 million A-shares.
Gelonghui reported on January 24 that LIVZON PHARMA (01513.HK) announced that on January 24, 2025, it spent 10.5315 million yuan to repurchase 0.2918 million A-shares, with a repurchase price ranging from 35.88 to 36.22 yuan per share.
On January 23, LIVZON PHARMA (01513.HK) spent 9.9967 million yuan to repurchase 0.2764 million A-shares.
On January 23, Gelonghui reported that LIVZON PHARMA (01513.HK) announced it spent 9.9967 million yuan to repurchase 0.2764 million A-shares on January 23, 2025, at a repurchase price of 36.02-36.36 yuan per share.
LIVZON PHARMA (01513.HK) spent 11.7541 million yuan to repurchase 0.3262 million A shares on January 22.
On January 22, Gelonghui reported that LIVZON PHARMA (01513.HK) announced the repurchase of 0.3262 million A shares at a cost of 11.7541 million yuan on January 22, 2025, with a repurchase price ranging from 35.9 to 36.21 yuan per share.
The Market Doesn't Like What It Sees From Livzon Pharmaceutical Group Inc.'s (SZSE:000513) Earnings Yet
